Next Article in Journal
The Peroxisome-Mitochondria Connection: How and Why?
Next Article in Special Issue
Suppression of Osteoclastogenesis by Melatonin: A Melatonin Receptor-Independent Action
Previous Article in Journal
Molecular Basis of Alcohol-Related Gastric and Colon Cancer
Previous Article in Special Issue
Melatonin Secretion Is Increased in Children with Severe Traumatic Brain Injury
Article Menu
Issue 6 (June) cover image

Export Article

Open AccessArticle
Int. J. Mol. Sci. 2017, 18(6), 1125;

Melatonin Attenuates Pulmonary Hypertension in Chronically Hypoxic Rats

School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China
Author to whom correspondence should be addressed.
Academic Editor: Russel J. Reiter
Received: 29 March 2017 / Revised: 19 May 2017 / Accepted: 19 May 2017 / Published: 24 May 2017
(This article belongs to the Special Issue Melatonin and Its Analogues: Experimental and Clinical Aspects)
Full-Text   |   PDF [5680 KB, uploaded 1 June 2017]   |  


Chronic hypoxia induces pulmonary hypertension and vascular remodeling, which are clinically relevant to patients with chronic obstructive pulmonary disease (COPD) associated with a decreased level of nitric oxide (NO). Oxidative stress and inflammation play important roles in the pathophysiological processes in COPD. We examined the hypothesis that daily administration of melatonin (10 mg/kg) mitigates the pulmonary hypertension and vascular remodeling in chronically hypoxic rats. The right ventricular systolic pressure (RVSP) and the thickness of pulmonary arteriolar wall were measured from normoxic control, vehicle- and melatonin-treated hypoxic rats exposed to 10% O2 for 14 days. Levels of markers for oxidative stress (malondialdhyde) and inflammation (tumor necrosis factor-α (TNFα), inducible NO synthase (iNOS) and cyclooxygenase-2 (COX-2)) and the expressions of total endothelial NO synthase (eNOS) and phosphorylated eNOS at serine1177 (ser1177) were determined in the lung tissue. We found that the RVSP and the thickness of the arteriolar wall were significantly increased in the vehicle-treated hypoxic animals with elevated levels of malondialdhyde and mRNA expressions of the inflammatory mediators, when compared with the normoxic control. In addition, the phosphorylated eNOS (ser1177) level was significantly decreased, despite an increased eNOS expression in the vehicle-treated hypoxic group. Melatonin treatment significantly attenuated the levels of RVSP, thickness of the arteriolar wall, oxidative and inflammatory markers in the hypoxic animals with a marked increase in the eNOS phosphorylation in the lung. These results suggest that melatonin attenuates pulmonary hypertension by antagonizing the oxidative injury and restoration of NO production. View Full-Text
Keywords: anti-oxidant; chronic hypoxia; inflammation; lung injury; nitric oxide anti-oxidant; chronic hypoxia; inflammation; lung injury; nitric oxide

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Hung, M.W.; Yeung, H.M.; Lau, C.F.; Poon, A.M.S.; Tipoe, G.L.; Fung, M.L. Melatonin Attenuates Pulmonary Hypertension in Chronically Hypoxic Rats. Int. J. Mol. Sci. 2017, 18, 1125.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top